Functioning of the Antioxidant Defense System in Rotenone-Induced Parkinson's Disease (vol 171, pg 716, 2021)

被引：0
|
作者：
Kryl'skii, E. D.
Razuvaev, G. A.
Potapova, T. N.
Akinina, A. I.
Nihaev, L. E.
机构：
[1] Voronezh State University,Department of Medical Biochemistry and Microbiology
来源：
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE | 2021年 / 172卷 / 01期
关键词：
D O I：
10.1007/s10517-021-05342-w
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：111 / 111
页数：1
相关论文
共 50 条
  • [31] Pharmacological evaluation of vanillic acid in rotenone-induced Parkinson's disease rat model
    Sharma, Neha
    Khurana, Navneet
    Muthuraman, Arunachalam
    Utreja, Puneet
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 903
  • [32] Rotenone-Induced Model of Parkinson’s Disease: Beyond Mitochondrial Complex I Inhibition
    María Teresa Ibarra-Gutiérrez
    Norma Serrano-García
    Marisol Orozco-Ibarra
    Molecular Neurobiology, 2023, 60 : 1929 - 1948
  • [33] Neurotherapeutic Effects of Bee Venom in a Rotenone-Induced Mouse Model of Parkinson's Disease
    Rakha, M. K.
    Tawfiq, R. A.
    Sadek, M. M.
    Anwer, M. A.
    Salama, S. M.
    Mohamed, A. F.
    El-Hendy, M. G.
    El-Said, Sh. E.
    Ahmed, N. M.
    Mekawi, K. S.
    Abd El-Aziz, A. M.
    Elmazar, M. M.
    NEUROPHYSIOLOGY, 2018, 50 (06) : 445 - 455
  • [34] Neuroprotective effects of Danshensu on rotenone-induced Parkinson’s disease models in vitro and in vivo
    Tian Wang
    Cuiting Li
    Bing Han
    Zhenhua Wang
    Xiaoyu Meng
    Leiming Zhang
    Jie He
    Fenghua Fu
    BMC Complementary Medicine and Therapies, 20
  • [35] Establishing the Rotenone-Induced Parkinson's Disease Animal Model in Wistar Albino Rats
    Swamy, Gangadhara
    Holla, Rajendra
    Rao, Suresh R.
    JOURNAL OF HEALTH AND ALLIED SCIENCES NU, 2021, 11 (03): : 158 - 163
  • [36] Neuroprotective role of silyamarin in stereotaxically rotenone-induced rat model of Parkinson's disease
    Khatri, D.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [37] Expression of phosphorylated α-synuclein is increased in the rotenone-induced rat model of Parkinson's disease
    Sui, L.
    Zhao, H.
    Yang, H.
    JOURNAL OF NEUROCHEMISTRY, 2008, 106 : 16 - 17
  • [38] The potential neuroprotective effect of diosmin in rotenone-induced model of Parkinson's disease in rats
    Habib, Christine N.
    Mohamed, Mohamed R.
    Tadros, Mariane G.
    Tolba, Mai F.
    Menze, Esther T.
    Masoud, Somia, I
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2022, 914
  • [39] Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson's disease
    Badawi, Ghada A.
    Abd El Fattah, Mai A.
    Zaki, Hala F.
    El Sayed, Moushira I.
    INFLAMMOPHARMACOLOGY, 2017, 25 (03) : 369 - 382
  • [40] Sitagliptin and liraglutide reversed nigrostriatal degeneration of rodent brain in rotenone-induced Parkinson’s disease
    Ghada A. Badawi
    Mai A. Abd El Fattah
    Hala F. Zaki
    Moushira I. El Sayed
    Inflammopharmacology, 2017, 25 : 369 - 382
12345